PCOS Renamed to PMOS: This New Name Could Transform Women's Health

Polycystic Ovary Syndrome (PCOS), one of the most misunderstood hormonal disorders affecting women, has officially been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change was announced publicly on May 12, 2026, following the publication of a global consensus study in The Lancet after a 14-year international effort involving medical experts, researchers and patient advocacy groups. The renaming marks a major shift in how the condition is understood medically and socially. For years, health professionals and patients argued that the term "PCOS" was inaccurate, misleading and overly focused on the ovaries. Many women diagnosed with the condition do not actually have ovarian cysts, yet the name continued to shape misconceptions about the disorder.

Why PCOS Was Renamed to PMOS

The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), better reflects the true nature of the condition. Medical experts now recognize it as a complex multisystem disorder involving hormonal, metabolic, reproductive, dermatological and even psychological health. It's been confirmed that it's not just ovarian issues. The initiative to rename PCOS to PMOS was led by the International PCOS Network alongside global endocrine and reproductive health experts, including researchers from Monash University in Australia. More than 50 medical organizations and thousands of women living with the condition contributed to the consultation process. According to Professor Helena Teede, one of the leading experts behind the initiative, the previous name narrowed the understanding of the disorder, contributing to delayed diagnosis and inadequate treatment. The condition affects an estimated one in eight women globally, yet studies suggest nearly 70% of cases remain undiagnosed. How the New Name will Improve Women's Health

The change is already happening. The new name is showing women that their health issues are worth researching and clarifying. Many women living with the condition see the change as validating. The transition from PCOS to PMOS is expected to improve awareness, diagnosis and long-term healthcare outcomes for millions of women. One major benefit is diagnostic clarity. The term "polycystic ovaries" often caused confusion among patients and even healthcare providers, especially when scans showed no ovarian cysts. This led some women to be dismissed or misdiagnosed despite experiencing severe symptoms such as irregular periods, infertility, insulin resistance, acne, weight changes, excess hair growth, anxiety and depression. PMOS encourages doctors to view the condition more holistically, by emphasizing endocrine and metabolic dysfunction. Experts believe this will push healthcare systems to focus not only on fertility and menstruation but also on cardiovascular health, diabetes risk, mental health, and obesity-related complications.

A New Era for Diagnosis and Awareness

Although the diagnostic criteria for the condition remains unchanged for now, the renaming to PMOS represents a broader recognition of women's health. For millions of women worldwide, PMOS may finally help healthcare providers see the condition for what it truly is: a whole-body health disorder rather than simply an ovarian problem.